Gene: FSTL3
Official Full Name: follistatin like 3provided by HGNC
Gene Summary: Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. It may have a role in leukemogenesis. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32042 | FSTL3 Knockout cell line (HeLa) | Human | FSTL3 | 1:3~1:6 | Negative | Online Inquiry |
KO32043 | FSTL3 Knockout cell line (HCT 116) | Human | FSTL3 | 1:2~1:4 | Negative | Online Inquiry |
KO32044 | FSTL3 Knockout cell line (HEK293) | Human | FSTL3 | 1:3~1:6 | Negative | Online Inquiry |
KO32045 | FSTL3 Knockout cell line (A549) | Human | FSTL3 | 1:3~1:4 | Negative | Online Inquiry |
FSTL3 Gene Knockout Cell Lines are genetically engineered cell lines that have had the FSTL3 gene selectively inactivated, providing a powerful platform for studying the role of this gene in various biological processes. The FSTL3 gene encodes a secreted glycoprotein that is implicated in modulating inflammation and tissue repair, making these knockout lines vital for exploring its functions in both physiological and pathological contexts.
These cell lines operate by employing CRISPR-Cas9 technology to precisely disrupt the FSTL3 gene, allowing researchers to investigate the downstream effects of its absence on cellular signaling pathways, gene expression profiles, and metabolic responses. By utilizing these knockout lines, scientists can uncover the mechanistic roles of FSTL3 in processes such as angiogenesis, fibrosis, and immune responses, important for developing targeted therapies in diseases like cancer, obesity, and autoimmune disorders.
The scientific importance of FSTL3 Gene Knockout Cell Lines extends to both basic and translational research, offering an invaluable tool for drug discovery and functional genomics. Unlike traditional gene silencing methods, these knockout cell lines provide a complete loss of function, enabling researchers to obtain more accurate data regarding gene function and interaction without the residual effects of partial knockdown or interference.
Researchers and clinicians will find unique value in these cell lines due to their high specificity, reproducibility, and ability to model human disease states more accurately than other available cell lines. Furthermore, these knockout lines offer a robust framework for the development of novel therapeutic interventions targeting FSTL3-related pathways, presenting a significant advantage over competing products.
With a strong commitment to cutting-edge genetic engineering and cell biology, our company pioneers the delivery of high-quality FSTL3 Gene Knockout Cell Lines, supported by our team’s extensive expertise in molecular genetics and a track record of excellence in biomolecular products. By choosing our product, researchers can confidently drive innovations in their studies and contribute to advancements in therapeutic strategies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.